4
Participants
Start Date
June 30, 2013
Primary Completion Date
July 31, 2013
Study Completion Date
October 31, 2013
hRESCAP
one acute bolus administration of different dosages of hRESCAP (microdose, part 1; and FIH: low dose, 414 µg; medium dose, 2480 µg; high dose, 5300 µg; part 2)
Placebo
Centre for Human Drug Research, Leiden
Collaborators (1)
Alloksys Life Sciences B.V.
INDUSTRY
TNO
OTHER